TG Therapeutics Inc (TGTX)
16.55
-0.21
(-1.25%)
USD |
NASDAQ |
Jun 14, 16:00
16.46
-0.09
(-0.54%)
After-Hours: 20:00
TG Therapeutics Total Liabilities (Quarterly): 213.21M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 213.21M |
December 31, 2023 | 169.08M |
September 30, 2023 | 166.30M |
June 30, 2023 | 180.40M |
March 31, 2023 | 169.92M |
December 31, 2022 | 134.98M |
September 30, 2022 | 117.41M |
June 30, 2022 | 122.63M |
March 31, 2022 | 132.64M |
December 31, 2021 | 142.48M |
September 30, 2021 | 98.17M |
June 30, 2021 | 98.27M |
March 31, 2021 | 103.41M |
December 31, 2020 | 106.29M |
September 30, 2020 | 103.20M |
June 30, 2020 | 100.39M |
March 31, 2020 | 103.20M |
December 31, 2019 | 124.40M |
September 30, 2019 | 119.12M |
June 30, 2019 | 93.38M |
March 31, 2019 | 98.28M |
December 31, 2018 | 59.58M |
September 30, 2018 | 42.63M |
June 30, 2018 | 39.34M |
March 31, 2018 | 35.76M |
Date | Value |
---|---|
December 31, 2017 | 30.39M |
September 30, 2017 | 22.24M |
June 30, 2017 | 23.22M |
March 31, 2017 | 22.21M |
December 31, 2016 | 18.91M |
September 30, 2016 | 18.93M |
June 30, 2016 | 16.10M |
March 31, 2016 | 10.62M |
December 31, 2015 | 11.90M |
September 30, 2015 | 11.10M |
June 30, 2015 | 10.66M |
March 31, 2015 | 11.04M |
December 31, 2014 | 6.645M |
September 30, 2014 | 10.46M |
June 30, 2014 | 4.206M |
March 31, 2014 | 3.742M |
December 31, 2013 | 8.058M |
September 30, 2013 | 9.662M |
June 30, 2013 | 7.584M |
March 31, 2013 | 6.688M |
December 31, 2012 | 6.524M |
September 30, 2012 | 7.338M |
June 30, 2012 | 6.744M |
March 31, 2012 | 5.887M |
December 31, 2011 | 4.901M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
93.38M
Minimum
Jun 2019
213.21M
Maximum
Mar 2024
129.95M
Average
120.87M
Median
Total Liabilities (Quarterly) Benchmarks
Eli Lilly and Co | 51.05B |
Alnylam Pharmaceuticals Inc | 4.044B |
Cytokinetics Inc | 1.204B |
Amicus Therapeutics Inc | 591.10M |
Insmed Inc | 1.624B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 373.32M |
Shareholders Equity (Quarterly) | 160.11M |
Debt to Equity Ratio | 0.6329 |
Current Ratio | 3.617 |
Net Debt Paydown Yield | -0.26% |